Sharon Tetlow

Sharon Tetlow has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Cell Genesys Inc, Gyre Therapeutics, Inc. and DICE Therapeutics, Inc. Between 30 July 2007 and 9 August 2023, the trades on record add up to 7 filings.

On the market, this insider has only ever bought: 1 purchase, €13k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 4 share grants.

The latest filing, published on 9 August 2023, reports a transaction in DICE Therapeutics, Inc. The last purchase on record was published on 15 July 2014, which is 4,484 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.